Approach
Pipeline
Patients
Company
Culture
Newsroom
Featured Post
16.07.2026
28.05.2026
Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026
28.04.2026
Theolytics Announces First Patient Dosed in the OCTOPOD-IP Trial, a US Phase 1 Trial with THEO-260, a Novel Oncolytic Immunotherapy Targeting Ovarian Cancer
04.03.2026
Theolytics Awarded €8 million in Horizon Europe 2025 Grant Funding to Advance Phase 2 Study of THEO-260 in Ovarian Cancer
13.10.2025
Theolytics to Present Ongoing Phase I/IIa OCTOPOD-IV Trial of THEO-260 in Ovarian Cancer at ESMO 2025 in Berlin
07.10.2025
Theolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer
17.12.2024
Theolytics Appoints David Apelian MD, PhD, MBA as CEO
19.11.2024
Theolytics Doses First Patient in Phase I/IIa Trial of THEO-260 in Ovarian Cancer
02.09.2024
Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK
17.04.2024
Theolytics successfully closes latest financing raising total of £19M ($24.5M) and welcomes Sound Bioventures as new investor
21.03.2024
Mike Grey appointed Executive Chair of Theolytics’ Board of Directors
28.11.2023
Theolytics presents data at ESMO on its lead program being developed for Ovarian Cancer
09.06.2023
Theolytics presents data on THEO-260 at ASCO and EHA
31.05.2022
Theolytics' £1M project with InnovateUK to develop a novel therapy
01.07.2021
Theolytics is taking part in the BIA Research Relay 2021
06.11.2020
Theolytics awarded Innovate UK boost to help combat ovarian cancer
07.01.2020
Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures
We’ll be attending these events over the coming months.
23rd - 24th September 2026
LSX Congress USA (LSX USA)
Boston, MA, USA
23rd - 25th September 2026
BioCentury Grand Rounds - Europe
Amsterdam, Netherlands
7th - 8th October 2026
Sachs Annual Biotech In Europe Forum
Basel, Switzerland
19th - 20th October 2026
3rd Annual Oncology Venture, Innovation & Partnering Summit
Cambridge, MA, USA
4th - 8th November 2026
SITC 2026
Phoenix, TX, USA
9th - 11th November 2026
BIO-Europe
Cologne, Germany
16th - 17th November 2026
LSX Investival Showcase
London, UK
